Till now, several molecular targeted drugs such as cetuxiumab (targeting EGFR) (9), trastuzumab (targeting HER2), and bevacizumab (targeting VEGF) have been used in the treatment of gastric cancer (5). Here, ERBB2 is linked to gastric cancer.